Levocarnitine for the Treatment of Polymorbid Patients
Effective and safe treatment of patients with polymorbidity is an urgent task of modern healthcare. Of particular difficulty is the treatment of patients with cardiovascular comorbidity, which requires an integrated approach to the treatment and development of a special, so-called patient-oriented a...
Saved in:
Main Authors: | A. P. Pereverzev (Author), D. A. Shevchenko (Author), A. V. Filippova (Author), A. A. Kirichenko (Author), I. F. Krotkova (Author), O. D. Ostroumova (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute kidney injury in polymorbid patients
by: Marina V. Lebedeva, et al.
Published: (2024) -
Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients
by: N. V. Izmozherova, et al.
Published: (2022) -
Meaningful use of ursodeoxycholic acid in a young polymorbid patient with arterial hypertension, obesity, and nonalcoholic fatty liver disease: a clinical case
by: Olga A. Polyakova, et al.
Published: (2023) -
Intradialytic hypotension frequency is reduced by levocarnitine supplementation
by: Stefano Aterini, et al.
Published: (2022) -
Polypharmacy and Polymorbidity in Older Adults in Brazil: a public health challenge
by: Luiz Roberto Ramos, et al.